Post-Exposure Prophylaxis in Health Care Workers
NCT01234116
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Human Immunodeficiency Virus
Interventions
DRUG:
emtricitabine/tenofovir disoproxil fumarate
Sponsor
Henry Ford Health System
Collaborators
[object Object]